enta's lead over pfe in covid has vanished - that could be putting pressure on enta shares I posted recently that PFE accrued their study ahead of schedule
Sounds about right. ENTA's stock price has drop more than I ever imagined. The FED raising interest rates so quickly sure hasn't helped biotech. My mistake in not factoring that into the equation.
Hopefully PFE will provide results so we can compare - I had speculated that at this point potential partners were probably waiting to see data from PFE and or Shionogi before partnering so at least you get some data sooner if you ask me